Crescent Biopharma

United States
Barbourmeade, Kentucky, United States, 20850

Company profile

Crescent Biopharma company profile

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines targeting verified biology to improve care for patients with solid tumors.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2024-01-01, Year

Headquarters

Postal code
20850
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
3
Total equity funding
$585M
Last funding
Post IPO Equity / $185M / 2025-12-04
Last equity funding
Post IPO Equity / $185M
Investors
21
Lead investors
3
Articles
66
Exited on
2025-06-16

Founders and investors

Lead investors

Biotechnology Value FundFairmount Funds ManagementVenrock Healthcare Capital Partners

Investors

Commodore CapitalFrazier Life SciencesPerceptive AdvisorsRTW InvestmentsWellington Management